1st patient recruited and randomised in PhINEST, a new RCT to confirm the positive outcomes of Phagenyx® treatment for patients with Post-Extubation Dysphagia

Pharyngeal Electrical Stimulation for the Treatment of Dysphagia After Extubation (The PhINEST Study) is a prospective, multi-site, randomised, sham-controlled, patient-masked, single-blind study. It is designed to assess the effects of Pharyngeal Electrical Stimulation (using the Phagenyx®system) for the treatment of oropharyngeal dysphagia after invasive mechanical ventilation in critically ill intensive care unit adult patients. For more information click here.

The Phagenyx® System was approved for sale in Europe in 2012 and is currently being used to treat patients with neurogenic dysphagia including post-extubation dysphagia.